| Period Ending: |
LTM
(Last Twelve Months) |
2024 12-31 |
2023 12-31 |
|---|---|---|---|
| Report Filing | 2025-09-30 | 2024-12-31 | 2023-12-31 |
| Revenue | 2.92 | 3.65 | 2.45 |
| Cost of Revenue | 4.11 | 14 | 12.72 |
| Gross Profit | -1.18 | -10.35 | -10.27 |
| Operating Expenses | 31.18 | 12.3 | 7.75 |
| Research & Development | 0.182 | 0 | 0 |
| Selling, General and Administrative | 31.12 | 12.11 | 7.65 |
| Other Operating Expenses | -0.131 | 0.192 | 0.098 |
| Operating Income | -32.36 | -22.65 | -18.02 |
| Net Non-Operating Interest | 0.061 | 0.795 | 1.11 |
| Interest Income | 0.063 | 0.795 | 1.11 |
| Interest Expense | 0.002 | 0 | 0 |
| Equity & Other Income/(Expense) | -182.8 | 0.279 | 0 |
| Income Before Tax | -215.1 | -21.58 | -16.91 |
| Income Tax Expense | 0 | 0 | 0 |
| Income Attributable to Non-Controlling Interest | 0 | 0 | 0 |
| Net Income | -215.1 | -21.58 | -16.91 |
| Depreciation and Amortization | 0.117 | 0.26 | 0.212 |
| EBITDA | -32.24 | -22.39 | -17.81 |
| Earnings Per Share (EPS) | -0.61 | 0 | 0 |
| Diluted Earnings Per Share | -0.61 | 0 | 0 |
| Weighted Average Shares Outstanding | 666.9 | 0 | 0 |
| Diluted Weighted Average Shares Outstanding | 666.9 | 0 | 0 |
